Want to see ALHC full AI Analyst Report?
ALHC Stock Chart & Stats
$19.43
-$0.41(-2.08%)
At close: 4:00 PM EDT
$19.43
-$0.41(-2.08%)
Day’s Range― - ―
52-Week Range$13.05 - $25.12
Previous CloseN/A
Volume698.37K
Average Volume (3M)4.63M
Market Cap
$2.74B
Enterprise Value$5.45K
Total Cash (Recent Filing)$701.71M
Total Debt (Recent Filing)$330.50M
Price to Earnings (P/E)67.8
Beta0.62
Next Earnings
Oct 29, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding207,435,150
10 Day Avg. Volume3,276,315
30 Day Avg. Volume4,629,108
Financial Highlights & Ratios
PEG Ratio53.67
Price to Book (P/B)21.81
Price to Sales (P/S)0.99
P/FCF Ratio34.56
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$21.86Price Target Upside12.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)0.19
Revenue Forecast (FY)$5.21B
Bulls Say, Bears Say
Bulls Say
Membership & Revenue ScaleSustained double‑digit membership and revenue growth demonstrates durable demand in the Medicare Advantage market and gives the company scale to negotiate provider contracts, spread fixed costs and improve per‑member economics as cohorts mature, supporting medium‑term profitability expansion.
Strong Cash Flow & Improved Balance SheetSubstantial cash reserves, positive operating and free cash flow, and sharply reduced reported debt materially enhance financial flexibility. This durable liquidity cushion supports growth investments, provider payments and regulatory volatility without relying on near‑term capital markets access.
Clinical/AI Platform & Embedded EarningsProprietary clinical analytics (AVA) and investments in registries/EHRs create sustainable competitive advantages by improving risk stratification and reducing high‑cost utilization. That capability underpins the company’s cited embedded gross profit runway and supports durable margin improvement as care management scales.
Bears Say
Very Thin Profit MarginsDespite revenue scale, operating profitability remains minimal, leaving the business highly sensitive to utilization shifts, pricing benchmarks or cost inflation. Sustaining positive ROE requires consistent margin improvement; any deterioration could quickly reverse recent earnings gains and strain capital.
High Acuity New Member MixA structural mix tilt toward higher‑acuity cohorts increases near‑term medical benefit ratios and pressure on margins until cohorts normalize. This persistently higher acuity profile can slow realized margin improvement and requires sustained clinical effectiveness to convert into long‑term cost benefits.
Regulatory Uncertainty & Reduced VisibilityPotential regulatory changes to Medicare Advantage rules and quality thresholds pose structural risk to future benchmarks, payments and star‑based bonuses. Coupled with reduced cadence of operational disclosures, this increases execution risk and makes it harder to monitor durable performance drivers.
Alignment Healthcare News
ALHC FAQ
What was Alignment Healthcare, Inc.’s price range in the past 12 months?
Alignment Healthcare, Inc. lowest stock price was $13.05 and its highest was $25.12 in the past 12 months.
What is Alignment Healthcare, Inc.’s market cap?
Alignment Healthcare, Inc.’s market cap is $2.74B.
When is Alignment Healthcare, Inc.’s upcoming earnings report date?
Alignment Healthcare, Inc.’s upcoming earnings report date is Oct 29, 2026 which is in 77 days.
How were Alignment Healthcare, Inc.’s earnings last quarter?
Alignment Healthcare, Inc. released its earnings results on Jul 30, 2026. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.129 by $0.041.
Is Alignment Healthcare, Inc. overvalued?
According to Wall Street analysts Alignment Healthcare, Inc.’s price is currently Undervalued.
Does Alignment Healthcare, Inc. pay dividends?
Alignment Healthcare, Inc. does not currently pay dividends.
What is Alignment Healthcare, Inc.’s EPS estimate?
Alignment Healthcare, Inc.’s EPS estimate is -0.01.
How many shares outstanding does Alignment Healthcare, Inc. have?
Alignment Healthcare, Inc. has 207,435,150 shares outstanding.
What happened to Alignment Healthcare, Inc.’s price movement after its last earnings report?
Alignment Healthcare, Inc. reported an EPS of $0.17 in its last earnings report, beating expectations of $0.129. Following the earnings report the stock price went down -20.204%.
Which hedge fund is a major shareholder of Alignment Healthcare, Inc.?
Currently, no hedge funds are holding shares in ALHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Alignment Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$21.86 (12.49% Upside)
$21.86 (12.49% Upside)
Blogger Sentiment
Bullish
ALHC Sentiment 71%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 149.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $197.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.0%
Last 30 Days ▼ 0.1%
Last 30 Days ▼ 0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.92%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
27.88%
Trailing 12-Months
Company Description
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.
ALHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a strong growth and margin-improvement story: membership and revenue grew ~31%-32% YoY, adjusted EBITDA rose 48% YoY, MBR improved ~40 bps, cash and leverage are healthy, and management raised revenue and profitability guidance while outlining sizable embedded earnings potential and meaningful clinical/AI investments. Offsetting these positives are intentional near-term investments that will increase Q3/Q4 MBR and SG&A (potentially a double-digit million impact), a smaller-than-last-year new-member sweep benefit, a modest prior-year reserve build (~$6M) and regulatory uncertainty. On balance, the company demonstrates operational execution and scalability while accepting some short-term cost headwinds to pursue longer-term growth and portability.View all ALHC earnings summariesALHC Stock 12 Month Forecast
Average Price Target
$21.86
▲(12.49% Upside)
Technical Analysis
Ownership Overview
16.74% Insiders
37.08% Mutual Funds
3.70% Other Institutional Investors
22.48% Public Companies and
Individual Investors